Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

L Platt, S Minozzi, J Reed, P Vickerman… - Cochrane Database …, 2017 - cochranelibrary.com
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

[HTML][HTML] Approaches, progress, and challenges to hepatitis C vaccine development

JR Bailey, E Barnes, AL Cox - Gastroenterology, 2019 - Elsevier
Risk factors for hepatitis C virus (HCV) infection vary, and there were an estimated 1.75
million new cases worldwide in 2015. The World Health Organization aims for a 90 …

[PDF][PDF] The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

J Grebely, K Page, R Sacks‐Davis… - …, 2014 - Wiley Online Library
Although 20%‐40% of persons with acute hepatitis C virus (HCV) infection demonstrate
spontaneous clearance, the time course and factors associated with clearance remain …

HCV epidemiology in high-risk groups and the risk of reinfection

H Midgard, A Weir, N Palmateer, VL Re III… - Journal of …, 2016 - Elsevier
Injecting risk behaviours among people who inject drugs (PWID) and high-risk sexual
practices among men who have sex with men (MSM) are important routes of hepatitis C …

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle… - PloS one, 2014 - journals.plos.org
Background People who inject drugs (PWID) are a key population affected by hepatitis C
virus (HCV). Treatment options are improving and may enhance prevention; however …

Acute hepatitis C in HIV-infected men who have sex with men: an emerging sexually transmitted infection

TJ Van De Laar, GV Matthews, M Prins, M Danta - Aids, 2010 - journals.lww.com
Since 2000 outbreaks of acute hepatitis C virus (HCV) among HIV-positive men who have
sex with men (MSM) who denied injecting drug use have been reported from Europe, the …

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine

J Grebely, M Prins, M Hellard, AL Cox… - The Lancet infectious …, 2012 - thelancet.com
Hepatitis C virus (HCV) was discovered more than two decades ago, but progress towards a
vaccine has been slow. HCV infection will spontaneously clear in about 25% of people …

What is killing people with hepatitis C virus infection?

J Grebely, GJ Dore - Seminars in liver disease, 2011 - thieme-connect.com
The burden of hepatitis C virus (HCV)-related morbidity and mortality continues to rise.
Progression to advanced liver disease among HCV-infected individuals generally requires …

Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM

FAE Lambers, M Prins, X Thomas, R Molenkamp… - Aids, 2011 - journals.lww.com
Background: Recent data indicate that seroprevalence of sexually transmitted hepatitis C
virus (HCV) infection among MSM is stabilizing in Amsterdam. However, little is known about …

Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study

N Islam, M Krajden, J Shoveller… - The lancet …, 2017 - thelancet.com
Background People remain at risk of reinfection with hepatitis C virus (HCV), even after
clearance of the primary infection. We identified factors associated with HCV reinfection risk …